共 50 条
- [23] Evolocumab in Pediatric Heterozygous Familial Hypercholesterolemia [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (01): : 84 - 84
- [24] Evolocumab in Pediatric Heterozygous Familial Hypercholesterolemia [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (14): : 1317 - 1327
- [25] PEDIATRIC IMPLICATIONS OF HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA - SCREENING AND DIETARY-TREATMENT [J]. ARTERIOSCLEROSIS, 1989, 9 (01): : I111 - I120
- [27] Cost-Effectiveness Analysis of Universal Screening for Biliary Atresia in Japan [J]. JOURNAL OF PEDIATRICS, 2023, 253 : 101 - +
- [28] COST-EFFECTIVENESS OF SCREENING FOR COLORECTAL CANCER IN ARGENTINA [J]. VALUE IN HEALTH, 2015, 18 (07) : A357 - A357
- [29] Cost-effectiveness of PCSK9 Inhibitor Therapy in Patients With Heterozygous Familial Hypercholesterolemia or Atherosclerotic Cardiovascular Disease [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2016, 316 (07): : 743 - 753